OTC Drugmaker CoLabs Int'l Withdraws IPO Filing
By Ben Glickman CoLabs Int'l, which develops technology to make over-the-counter drugs, has requested the withdrawal of its initial public offering filing....
Source: marketwatch.com
Stay updated with breaking news from Quantasphere Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Ben Glickman CoLabs Int'l, which develops technology to make over-the-counter drugs, has requested the withdrawal of its initial public offering filing....